Cerevel Therapeutics (CERE) PT Raised to $37 as Jefferies Call Plays Out As Expected
Tweet Send to a Friend
Jefferies analyst Michael J. Yee raised the price target on Cerevel Therapeutics (NASDAQ: CERE) to $37.00 (from $22.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
